UZ Leuven Dept of Radiology
Leuven, Vlaams Brabant, 3000, Belgium
NCT Number: NCT01466010
Purpose of the study:
To retrospectively determine the clinical results in an unselected group of consecutive patients with osteoid osteoma treated by surgery.
Materials and Methods:
In 150 consecutive patients with clinical and/or radiological evidence for osteoid osteoma at any location, the clinical symptoms and imaging findings (radiographs and computed tomography (CT)) were assessed before and after surgery. There were no exclusion criteria for this study. A good response was defined as disappearance of symptoms that were manifested at presentation and were attributed to osteoid osteoma. Clinical assessment after the procedure was performed prior to discharge; within 2 weeks after the procedure; and at 3, 6, and 12 months follow-up. After 24 months, a postal questionnaire was used for assessment. Radiographic evaluation (radiographs and thin-slice CT) was performed routinely pre-operatively and one year after surgery.
In case of persisting or recurring symptoms the follow-up protocol was again performed according to the initial protocol.
All patients gave their informed consent both for the surgical intervention as for the use of their patient data in this retrospective study.
Looking for future studies?
Notify Me2 year–70 year
All sexes
Observational
Leuven, Vlaams Brabant, 3000, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
surgery for osteoid osteoma: this may include curettage or en-bloc resection of the lesion
Universitaire Ziekenhuizen KU Leuven
Other
Treatment Outcome After Surgical Treatment of Osteoid Osteoma, a Retrospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02618369
Benign Bone Tumor, Neoplasms
Toronto, Ontario, Canada
View Trial DetailsNCT02349971
Neoplasms, Neoplasms by Histologic Type
Washington D.C., District of Columbia, United States
View Trial DetailsNCT04658771
Neoplasms, Neoplasms by Histologic Type
Washington D.C., District of Columbia, United States
View Trial DetailsNCT02923011
Neoplasms, Neoplasms by Histologic Type
Palo Alto, California, United States
View Trial Details